DSMB

DSMB may stand for:

  • Delayed Surface Marker Buoy, an inflatable buoy used by SCUBA divers
  • Data and safety monitoring board, an independent group of experts who monitor patient safety and treatment efficacy data while a clinical trial is ongoing
    • Read more
    This page contains text from Wikipedia, the Free Encyclopedia - https://wn.com/DSMB

    Podcasts:

    Email this Page Play all in Full Screen Show More Related Videos
    PLAYLIST TIME:

    Latest News for: dsmb

    BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 ...

    Nasdaq Globe Newswire 15 Apr 2025
    Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group ... .

    BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial (Form 8-K) (BioCardia Inc)

    Public Technologies 15 Apr 2025
    BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial. Independent Data Safety Monitoring Board (DSMB) recommends that the study ...

    MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 ...

    Business Wire 08 Apr 2025
    LYON, France--(BUSINESS WIRE)---- $MAAT #Cancer--MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT ... .

    April 8, 2025: MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT (Maat Pharma SA)

    Public Technologies 08 Apr 2025
    ) MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT ... The routine DSMB review for ongoing safety, conducted every six months, is also expected for Q3 2025.

    MaaT Pharma Announces Positive Safety Interim Analysis from DSMB for Phase 2b Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT (Maat Pharma SA)

    Public Technologies 08 Apr 2025
    ) Following a milestone unblinded interim safety review, the independent Data Safety Monitoring Board (DSMB) has recommended that the study proceed without modification ... The next DSMB unblinded interim ...
    • 1

    Article Search

    tools
    ×
    ×
    ×
    ×